SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-17-265667
Filing Date
2017-08-23
Accepted
2017-08-23 16:28:26
Documents
8
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d426749dsc13ga.htm SC 13G/A 58619
2 EX-99.1 d426749dex991.htm EX-99.1 976
3 EX-99.2 d426749dex992.htm EX-99.2 10217
4 EX-99.3 d426749dex993.htm EX-99.3 4719
5 EX-99.4 d426749dex994.htm EX-99.4 6081
6 GRAPHIC g426749g26y03.jpg GRAPHIC 60874
7 GRAPHIC g426749g59p86.jpg GRAPHIC 24538
8 GRAPHIC g426749g92f00.jpg GRAPHIC 10126
  Complete submission text file 0001193125-17-265667.txt   214378
Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Filed by) CIK: 0001297709 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Subject) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80900 | Film No.: 171047389
SIC: 2834 Pharmaceutical Preparations